Fresh Tracks Therapeutics, Inc. Profile Avatar - Palmy Investing

Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company dev…

Biotechnology
US, Boulder [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
Fresh Tracks Therapeutics, Inc. can't present any analysts estimates at the moment detail analysis.
End of FRTX's Analysis
CIK: 819050 CUSIP: - ISIN: US10802T2042 LEI: - UEI: -
Secondary Listings
FRTX has no secondary listings inside our databases.